Literature DB >> 15615388

[Pharyngeal carriage of Neisseria meningitidis in a school of Niamey, Niger].

S Djibo1, P Nicolas, G Campagne, J P Chippaux.   

Abstract

This study of pharyngeal carriage of Neisseria meningitidis in a school in Niamey, Nigeria was carried out to confirm the feasibility of evaluating the impact of conjugate vaccine on the meningococcal carriage. All 90 pupils attending the school were examined during the dry season in February 1998. All children had been vaccinated using polysaccharide A/C in 1996. Samples were collected from the soft palate and immediately seeded on selective medium. After incubation at 37 degrees C for 24 hours, suspicious colonies were re-seeded on Miller-Hinton medium. Identification of N. meningitidis was based on standard biochemical criteria, agglutination grouping and DNA fingerprinting. Seven carriers of N. meningitidis X:NT:P1.5 were found. One of these carriers also presented a strain of N. meningitis A:4:P1.9. The high prevalence of serogroup X strains coincided with an outbreak of meningitis involving the same sub-type and sequence-type in Niamey.

Entities:  

Mesh:

Year:  2004        PMID: 15615388

Source DB:  PubMed          Journal:  Med Trop (Mars)        ISSN: 0025-682X


  3 in total

1.  Molecular epidemiology of neisseria meningitidis isolated in the African Meningitis Belt between 1988 and 2003 shows dominance of sequence type 5 (ST-5) and ST-11 complexes.

Authors:  Pierre Nicolas; Gunnstein Norheim; Eric Garnotel; Saacou Djibo; Dominique A Caugant
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

Review 2.  Incidence, carriage and case-carrier ratios for meningococcal meningitis in the African meningitis belt: a systematic review and meta-analysis.

Authors:  Thibaut Koutangni; Halima Boubacar Maïnassara; Judith E Mueller
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

3.  Evolution of meningococcal carriage in serogroups X and Y before introduction of MenAfriVac in the health district of Kaya, Burkina Faso.

Authors:  Absatou Ky Ba; Idrissa Sanou; Paul A Kristiansen; Lassana Sangaré; Rasmata Ouédraogo; Kalifa Ouattara; Maxime Kienou; Simon Tiendrebeogo; Juliette Tranchot
Journal:  BMC Infect Dis       Date:  2014-10-14       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.